Advertisement Contracts Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Contracts

June 15, 2021

GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug

GlaxoSmithKline (GSK) and iTeos Therapeutics have signed an agreement to co-develop and co-commercialise EOS-448, an anti-TIGIT monoclonal antibody presently under phase I development as a potential treatment for cancer patients.

GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug